Publications by authors named "Jan Lastovicka"

Claim this Profile
C
Content and specificity of the Anti-SARS-CoV-2 antibodies in solutions for immunoglobulin replacement therapy.
Tomas Milota, Jitka Smetanova, Hana Zelena, Michal Rataj, Jan Lastovicka

Int Immunopharmacol· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical Outcomes, Immunogenicity, and Safety of BNT162b2 Vaccine in Primary Antibody Deficiency.
Tomas Milota, Jitka Smetanova, Aneta Skotnicova, Michal Rataj, Jan Lastovicka

J Allergy Clin Immunol Pract· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effectiveness and Durability of mRNA Vaccine-Induced SARS-CoV-2-Specific Humoral and Cellular Immunity in Severe Asthma Patients on Biological Therapy.
Michal Podrazil, Pavla Taborska, Dmitry Stakheev, Michal Rataj, Jan Lastovicka

Front Immunol· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impaired Humoral Response to Third Dose of BNT162b2 mRNA COVID-19 Vaccine Despite Detectable Spike Protein-specific T cells in Lung Transplant Recipients.
Jan Havlin, Aneta Skotnicova, Eliska Dvorackova, Petr Hubacek, Monika Svorcova, Jan Lastovicka

Transplantation· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immunogenicity and Safety of COVID-19 mRNA Vaccine in STAT1 GOF Patients.
Marketa Bloomfield, Zuzana Parackova, Jana Hanzlikova, Jan Lastovicka, Anna Sediva

J Clin Immunol· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
SARS-CoV-2 spike glycoprotein-reactive T cells can be readily expanded from COVID-19 vaccinated donors.
Pavla Taborska, Jan Lastovicka, Dmitry Stakheev, Zuzana Strizova, Jirina Bartunkova

Immun Inflamm Dis· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immunogenicity of BNT162b2 mRNA COVID-19 vaccine and SARS-CoV-2 infection in lung transplant recipients.
Jan Havlin, Monika Svorcova, Eliska Dvorackova, Jan Lastovicka, Robert Lischke

J Heart Lung Transplant· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reliability of Autoantibodies Against a Tissue Transglutaminase Neo-Epitope for the Diagnosis of Pediatric Celiac Disease.
Jiri Nevoral, Ondrej Hradsky, Jan Lastovicka, Eva Neubertova, Jindra Reissigova

Clin Lab· January 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Assessment of lymphocyte proliferation for diagnostic purpose: Comparison of CFSE staining, Ki-67 expression and H-thymidine incorporation.
Jan Lašťovička, Michal Rataj, Jiřina Bartůňková

Hum Immunol· December 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase I/II clinical trial of dendritic-cell based immunotherapy (DCVAC/PCa) combined with chemotherapy in patients with metastatic, castration-resistant prostate cancer.
Michal Podrazil, Rudolf Horvath, Etienne Becht, Daniela Rozkova, Pavla Bilkova, Jan Lastovicka

Oncotarget· July 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical relevance of regulatory T cells monitoring in the peripheral blood of ovarian cancer patients.
Tomáš Brtnický, Anna Fialová, Jan Laštovička, Lukáš Rob, Radek Špíšek

Hum Immunol· March 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Symptom positivity is essential for omitting biopsy in children with suspected celiac disease according to the new ESPGHAN guidelines.
Jiri Nevoral, Radana Kotalova, Ondrej Hradsky, Vera Valtrova, Kristyna Zarubova, Jan Lastovicka

Eur J Pediatr· November 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Regulatory T cells, dendritic cells and neutrophils in patients with renal cell carcinoma.
Ivo Minárik, Jan Lašťovička, Vít Budinský, Jana Kayserová, Radek Spíšek

Immunol Lett· May 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
FOCUS on FOCIS: combined chemo-immunotherapy for the treatment of hormone-refractory metastatic prostate cancer.
Daniela Rozková, Hana Tiserová, Jitka Fucíková, Jan Last'ovicka, Michal Podrazil

Clin Immunol· April 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis